Literature DB >> 8669932

Severe aplastic anaemia in the Nordic countries: a population based study of incidence, presentation, course, and outcome.

N Clausen1, A Kreuger, T Salmi, I Storm-Mathisen, G Johannesson.   

Abstract

PURPOSE: Incidence data for severe aplastic anaemia (SAA) in children are scanty and vary. Few population based studies have been reported. A retrospective and prospective study was conducted to determine the incidence and course of SAA. PATIENTS AND METHODS: All children with a diagnosis of SAA in the Nordic countries from 1982 through 1993 were registered and have been followed up since 1987.
RESULTS: A total of 101 children were diagnosed with SAA. The mean annual child population was 4.31 million. A constant incidence of 1.95/million children/year was found: 2.4 for boys and 1.5 for girls. A non-significant increase of cases occurred from November to March. Possible aetiological agents were noted in 29%. The actuarial survival was 79% after one year and 68% after five years without significant difference between boys and girls.
CONCLUSION: The incidence of SAA in the Nordic countries remains stable with a preponderance among boys. SAA has still a high initial mortality and a risk of late deaths.

Entities:  

Mesh:

Year:  1996        PMID: 8669932      PMCID: PMC1511473          DOI: 10.1136/adc.74.4.319

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Aplastic anaemia. I. Incidence and aetiology.

Authors:  L E Böttiger; B Westerholm
Journal:  Acta Med Scand       Date:  1972-10

2.  Incidence of aplastic anemia in metropolitan Baltimore: a population-based study.

Authors:  M Szklo; L Sensenbrenner; J Markowitz; S Weida; S Warm; M Linet
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

3.  Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia.

Authors:  J Y Mary; E Baumelou; M Guiguet
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

4.  Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia.

Authors:  E Bayever; R Champlin; W Ho; C Lenarsky; S Storch; S Ladisch; R P Gale; S A Feig
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

Review 5.  Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results.

Authors:  B M Camitta; K Doney
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

Review 6.  Drug-induced aplastic anemia: pathogenesis and clinical aspects.

Authors:  D Malkin; G Koren; E F Saunders
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

7.  Outcome of moderate aplastic anemia in children.

Authors:  Z Khatib; J Wilimas; W Wang
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-02

8.  Cyclosporine A in a case of refractory severe aplastic anaemia.

Authors:  M Seip; J Vidnes
Journal:  Scand J Haematol       Date:  1985-03

9.  A population study of severe aplastic anemia in children. Incidence, etiology and course.

Authors:  N Clausen
Journal:  Acta Paediatr Scand       Date:  1986-01

10.  Aplastic anaemia incidence in parts of the United Kingdom in 1985.

Authors:  R A Cartwright; P A McKinney; L Williams; J G Miller; D I Evans; D P Bentley; M Bhavnani
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

View more
  6 in total

1.  IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.

Authors:  Fan-ching Lin; Megan Karwan; Bahara Saleh; Deborah L Hodge; Tim Chan; Kimberly C Boelte; Jonathan R Keller; Howard A Young
Journal:  Blood       Date:  2014-10-23       Impact factor: 22.113

2.  The epidemiology of aplastic anemia in Thailand.

Authors:  Surapol Issaragrisil; David W Kaufman; Theresa Anderson; Kanchana Chansung; Paul E Leaverton; Samuel Shapiro; Neal S Young
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

3.  Etiology and survival of aplastic anemia: a study based on clinical investigation.

Authors:  Dharmendra Jain; Ritesh Kumar; Neetu Tyagi; Avinash Negi; Amit Pande; Amita Mahajan; Prashant K Pandey; Radhika Malik; Vimarsh Raina; Balwant K Malik
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

4.  Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients.

Authors:  Daria V Babushok; Yimei Li; Jacquelyn J Roth; Nieves Perdigones; Joshua D Cockroft; Jaclyn A Biegel; Philip J Mason; Monica Bessler
Journal:  Am J Hematol       Date:  2013-07-23       Impact factor: 10.047

5.  Improved prognosis for acquired aplastic anaemia.

Authors:  L A Pitcher; I M Hann; J P Evans; P Veys; J M Chessells; D K Webb
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

6.  Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011.

Authors:  Krista Vaht; Magnus Göransson; Kristina Carlson; Cecilia Isaksson; Stig Lenhoff; Anna Sandstedt; Bertil Uggla; Jacek Winiarski; Per Ljungman; Mats Brune; Per-Ola Andersson
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.